BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of ($0.32), $0.11 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $37.7 million versus the consensus estimate of $42.92 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.